The latest study on Point-of-Care Molecular Diagnostics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Point-of-Care Molecular Diagnostics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Point-of-Care Molecular Diagnostics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Abbott Laboratories, Bayer Healthcare
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Point-of-Care Molecular Diagnostics Market Analysis By Type Segment:
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
Point-of-Care Molecular Diagnostics Market Analysis By Application Segment:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
Point-of-Care Molecular Diagnostics Market Analysis By Regions (Countries):
The Point-of-Care Molecular Diagnostics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Point-of-Care Molecular Diagnostics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Point-of-Care Molecular Diagnostics Market:
Point-of-Care Molecular Diagnostics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Point-of-Care Molecular Diagnostics Market status and future forecast.
To present the key Point-of-Care Molecular Diagnostics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type (2016-2027)
1.4.2 PCR-based
1.4.3 Genetic Sequencing-based
1.4.4 Hybridization-based
1.4.5 Microarray-based
1.5 Market by Application
1.5.1 Global Point-of-Care Molecular Diagnostics Market Share by Application (2021-2027)
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Hematology
1.5.5 Prenatal Testing
1.5.6 Endocrinology
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Point-of-Care Molecular Diagnostics Market Size
2.2 Point-of-Care Molecular Diagnostics Growth Trends by Regions
2.2.1 Point-of-Care Molecular Diagnostics Market Size by Regions (2021-2027)
2.2.2 Point-of-Care Molecular Diagnostics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter s Five Forces Analysis
3 Market Share by Key Players
3.1 Point-of-Care Molecular Diagnostics Market Size by by Players
3.1.1 Global Point-of-Care Molecular Diagnostics Revenue by by Players (2020)
3.1.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by by Players (2020)
3.1.3 Global Point-of-Care Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Point-of-Care Molecular Diagnostics Key Players Head office and Area Served
3.3 Key Players Point-of-Care Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into Point-of-Care Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Point-of-Care Molecular Diagnostics Market Size by Type (2016-2020)
4.2 Global Point-of-Care Molecular Diagnostics Market Size by Application (2016-2020)
5 North America
5.1 North America Point-of-Care Molecular Diagnostics Market Size (2016-2020)
5.2 Point-of-Care Molecular Diagnostics Key Players in North America
5.3 North America Point-of-Care Molecular Diagnostics Market Size by Type
5.4 North America Point-of-Care Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe Point-of-Care Molecular Diagnostics Market Size (2016-2020)
6.2 Point-of-Care Molecular Diagnostics Key Players in Europe
6.3 Europe Point-of-Care Molecular Diagnostics Market Size by Type
6.4 Europe Point-of-Care Molecular Diagnostics Market Size by Application
7 China
7.1 China Point-of-Care Molecular Diagnostics Market Size (2016-2020)
7.2 Point-of-Care Molecular Diagnostics Key Players in China
7.3 China Point-of-Care Molecular Diagnostics Market Size by Type
7.4 China Point-of-Care Molecular Diagnostics Market Size by Application
8 Japan
8.1 Japan Point-of-Care Molecular Diagnostics Market Size (2016-2020)
8.2 Point-of-Care Molecular Diagnostics Key Players in Japan
8.3 Japan Point-of-Care Molecular Diagnostics Market Size by Type
8.4 Japan Point-of-Care Molecular Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Point-of-Care Molecular Diagnostics Market Size (2016-2020)
9.2 Point-of-Care Molecular Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type
9.4 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application
10 India
10.1 India Point-of-Care Molecular Diagnostics Market Size (2016-2020)
10.2 Point-of-Care Molecular Diagnostics Key Players in India
10.3 India Point-of-Care Molecular Diagnostics Market Size by Type
10.4 India Point-of-Care Molecular Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Point-of-Care Molecular Diagnostics Market Size (2016-2020)
11.2 Point-of-Care Molecular Diagnostics Key Players in Central & South America
11.3 Central & South America Point-of-Care Molecular Diagnostics Market Size by Type
11.4 Central & South America Point-of-Care Molecular Diagnostics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories, Bayer Healthcare
12.1.1 Abbott Laboratories, Bayer Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Point-of-Care Molecular Diagnostics Introduction
12.1.4 Abbott Laboratories, Bayer Healthcare Revenue in Point-of-Care Molecular Diagnostics Business (2020))
12.1.5 Abbott Laboratories, Bayer Healthcare Recent Development
12.2 F. Hoffmann-La Roche AG
12.2.1 F. Hoffmann-La Roche AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Point-of-Care Molecular Diagnostics Introduction
12.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.2.5 F. Hoffmann-La Roche AG Recent Development
12.3 Becton, Dickinson and Company
12.3.1 Becton, Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Point-of-Care Molecular Diagnostics Introduction
12.3.4 Becton, Dickinson and Company Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.3.5 Becton, Dickinson and Company Recent Development
12.4 BioMerieux
12.4.1 BioMerieux Company Details
12.4.2 Company Description and Business Overview
12.4.3 Point-of-Care Molecular Diagnostics Introduction
12.4.4 BioMerieux Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.4.5 BioMerieux Recent Development
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Bio-Rad Laboratories, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Point-of-Care Molecular Diagnostics Introduction
12.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.5.5 Bio-Rad Laboratories, Inc. Recent Development
12.6 Cepheid, Inc.
12.6.1 Cepheid, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Point-of-Care Molecular Diagnostics Introduction
12.6.4 Cepheid, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.6.5 Cepheid, Inc. Recent Development
12.7 Danaher Corporation
12.7.1 Danaher Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Point-of-Care Molecular Diagnostics Introduction
12.7.4 Danaher Corporation Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.7.5 Danaher Corporation Recent Development
12.8 Johnson and Johnson
12.8.1 Johnson and Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Point-of-Care Molecular Diagnostics Introduction
12.8.4 Johnson and Johnson Revenue in Point-of-Care Molecular Diagnostics Business (2020)
12.8.5 Johnson and Johnson Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Product (2021-2027)
13.2 Market Size Forecast by Application (2021-2027)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Point-of-Care Molecular Diagnostics Key Market Segments
Table Key Players Point-of-Care Molecular Diagnostics Covered
Table Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type 2021-2027 (Million US$)
Figuer PCR-based Figures
Table Key Players of PCR-based
Figuer Genetic Sequencing-based Figures
Table Key Players of Genetic Sequencing-based
Figuer Hybridization-based Figures
Table Key Players of Hybridization-based
Figuer Microarray-based Figures
Table Key Players of Microarray-based
Table Global Point-of-Care Molecular Diagnostics Market Size Growth by Application 2021-2027 (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Share by Application in 2020 & 2027
Figure Infectious Diseases Case Studies
Figure Oncology Case Studies
Figure Hematology Case Studies
Figure Prenatal Testing Case Studies
Figure Endocrinology Case Studies
Figure Other Case Studies
Figure Point-of-Care Molecular Diagnostics Report Years Considered
Figure Global Point-of-Care Molecular Diagnostics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions 2021-2027 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions 2021-2027 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Share by Regions 2016-2020
Figure Global Point-of-Care Molecular Diagnostics Market Share by Regions 2016-2020
Figure Global Point-of-Care Molecular Diagnostics Market Share by Regions in 2020
Table Market Top Trends
Table Key Drivers: Impact Analysis (2021-2027)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Point-of-Care Molecular Diagnostics Revenue by by Players (2020) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Share by by Players (2020)
Figure Global Point-of-Care Molecular Diagnostics Market Share by by Players in 2020
Table Global Point-of-Care Molecular Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Point-of-Care Molecular Diagnostics Product/Solution/Service
Table Date of Enter into Point-of-Care Molecular Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Point-of-Care Molecular Diagnostics Market Size by Type (2016-2020) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size Share by Type (2016-2020)
Figure Global Point-of-Care Molecular Diagnostics Market Size Market Share by Type (2016-2020)
Table Global Point-of-Care Molecular Diagnostics Market Size by Application (2016-2020) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size Share by Application (2016-2020)
Figure Global Point-of-Care Molecular Diagnostics Market Size Market Share by Application (2016-2020)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application in 2020
Figure North America Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table North America Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table North America Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table North America Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table North America Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table North America Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table North America Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure Europe Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Europe Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table Europe Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table Europe Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table Europe Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table Europe Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table Europe Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure China Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table China Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table China Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table China Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table China Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table China Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table China Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure Japan Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Japan Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table Japan Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table Japan Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table Japan Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table Japan Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table Japan Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure Southeast Asia Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure India Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table India Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table India Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table India Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table India Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table India Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table India Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Figure Central & South America Point-of-Care Molecular Diagnostics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Point-of-Care Molecular Diagnostics Revenue (2020) (Million US$)
Table Central & South America Key Players Point-of-Care Molecular Diagnostics Market Share (2020)
Table Central & South America Point-of-Care Molecular Diagnostics Market Size by Type 2016-2020 (Million US$)
Table Central & South America Point-of-Care Molecular Diagnostics Market Share by Type 2016-2020
Table Central & South America Point-of-Care Molecular Diagnostics Market Size by Application 2016-2020 (Million US$)
Table Central & South America Point-of-Care Molecular Diagnostics Market Share by Application 2016-2020
Table Abbott Laboratories, Bayer Healthcare Company Details
Table Abbott Laboratories, Bayer Healthcare Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Abbott Laboratories, Bayer Healthcare Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Abbott Laboratories, Bayer Healthcare Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table F. Hoffmann-La Roche AG Recent Development
Table Becton, Dickinson and Company Company Details
Table Becton, Dickinson and Company Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Becton, Dickinson and Company Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Becton, Dickinson and Company Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure BioMerieux Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table BioMerieux Recent Development
Table Bio-Rad Laboratories, Inc. Company Details
Table Bio-Rad Laboratories, Inc. Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Bio-Rad Laboratories, Inc. Recent Development
Table Cepheid, Inc. Company Details
Table Cepheid, Inc. Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Cepheid, Inc. Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Cepheid, Inc. Recent Development
Table Danaher Corporation Company Details
Table Danaher Corporation Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Danaher Corporation Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Danaher Corporation Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Point-of-Care Molecular Diagnostics Business 2020 (Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2020)
Table Johnson and Johnson Recent Development
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions (Million US$) 2021-2027
Figure Global Point-of-Care Molecular Diagnostics Market Size Share by Regions (2021-2027)
Figure Global Point-of-Care Molecular Diagnostics Market Size Share by Regions in 2027
Figure North America Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure China Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure India Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Point-of-Care Molecular Diagnostics Market Size Forecast (2021-2027)(Million USD)
Table Global Point-of-Care Molecular Diagnostics Market Size by Product (2021-2027) (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Product (2021-2027)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Product in 2027
Table Global Point-of-Care Molecular Diagnostics Market Size by Application (2021-2027) (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Application (2021-2027)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources